In Treatment of Overactive bladder (OAB) symptoms Nocturin 2.5mg Tablet helps to treat uncontrollable contractions (spasms) of the bladder muscles that causes frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
Nocturin 2.5mg Tablet may cause excessive drowsiness with alcohol.
Nocturin 2.5mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Nocturin 2.5mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Nocturin 2.5mg Tablet may cause side effects which could affect your ability to drive. You may feel drowsy or have blurred vision while you are taking Nocturin 2.5mg Tablet. This may affect your driving ability.
Nocturin 2.5mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nocturin 2.5mg Tablet may be needed. Please consult your doctor.
Nocturin 2.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Nocturin 2.5mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Nocturin 2.5mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)